OMERS ADMINISTRATION Corp Invests $1.51 Million in Astera Labs, Inc. $ALAB

OMERS ADMINISTRATION Corp acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 3,120 shares of the company’s stock, valued at approximately $1,507,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ALAB. Glenmede Trust Co. NA increased its holdings in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the last quarter. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the second quarter valued at $25,000. Lido Advisors LLC grew its position in shares of Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares during the period. Goldstein Advisors LLC grew its position in shares of Astera Labs by 5.8% in the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after acquiring an additional 88 shares during the period. Finally, Johnson Financial Group Inc. acquired a new position in shares of Astera Labs during the 2nd quarter worth about $43,000. 60.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on ALAB shares. Susquehanna upped their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Bank of America boosted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Stifel Nicolaus raised their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Finally, Morgan Stanley lifted their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the transaction, the director owned 3,970 shares in the company, valued at approximately $1,237,965.10. This trade represents a 69.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 419,244 shares of company stock valued at $163,135,169. Insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ ALAB opened at $290.30 on Thursday. The stock has a market cap of $50.36 billion, a PE ratio of 143.71 and a beta of 3.84. The firm has a 50-day moving average of $347.19 and a 200-day moving average of $248.42. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.